Dakota Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.1M Buy
233,345
+52,548
+29% +$6.07M 0.61% 42
2025
Q4
$19M Buy
180,797
+149,486
+477% +$14M 0.34% 57
2025
Q3
$2.63M Sell
31,311
-4,634
-13% -$382K 0.05% 218
2025
Q2
$2.85M Buy
35,945
+114
+0.3% +$9.06K 0.06% 218
2025
Q1
$3.22M Sell
35,831
-3,766
-10% -$352K 0.08% 195
2024
Q4
$3.94M Sell
39,597
-42,660
-52% -$4.4M 0.09% 177
2024
Q3
$9.34M Buy
82,257
+6,968
+9% +$828K 0.21% 97
2024
Q2
$9.32M Buy
75,289
+2,997
+4% +$386K 0.22% 94
2024
Q1
$9.54M Buy
72,292
+19,874
+38% +$2.45M 0.24% 93
2023
Q4
$5.72M Sell
52,418
-845
-2% -$87.7K 0.22% 110
2023
Q3
$5.48M Sell
53,263
-78,994
-60% -$8.51M 0.24% 105
2023
Q2
$15.3M Buy
132,257
+13,040
+11% +$1.48M 0.72% 32
2023
Q1
$12.7M Buy
119,217
+96,819
+432% +$10.5M 0.85% 26
2022
Q4
$2.49M Buy
22,398
+956
+4% +$97.7K 0.18% 132
2022
Q3
$1.85M Sell
21,442
-1,440
-6% -$129K 0.15% 153
2022
Q2
$2.09M Sell
22,882
-12,572
-35% -$1.11M 0.19% 128
2022
Q1
$2.91M Sell
35,454
-47,834
-57% -$3.77M 0.24% 116
2021
Q4
$6.38M Sell
83,288
-12,396
-13% -$987K 0.67% 37
2021
Q3
$7.19M Buy
95,684
+92,480
+2,886% +$7.03M 0.83% 26
2021
Q2
$249K Sell
3,204
-509
-14% -$37.9K 0.03% 300
2021
Q1
$273K Sell
3,713
-9,353
-72% -$690K 0.04% 270
2020
Q4
$1.02M Buy
13,066
+4,458
+52% +$341K 0.13% 144
2020
Q3
$681K Sell
8,608
-30,727
-78% -$2.41M 0.11% 146
2020
Q2
$2.9M Sell
39,335
-13,835
-26% -$1.04M 0.5% 59
2020
Q1
$3.9M Sell
53,170
-9,902
-16% -$778K 0.85% 35
2019
Q4
$5.47M Buy
63,072
+5,396
+9% +$443K 0.88% 32
2019
Q3
$4.63M Buy
57,676
+24,014
+71% +$1.92M 0.8% 36
2019
Q2
$2.69M Sell
33,662
-607
-2% -$46.5K 0.52% 54
2019
Q1
$2.72M Sell
34,269
-700
-2% -$52.4K 0.54% 51
2018
Q4
$2.38M Buy
34,969
+34
+0.1% +$2.4K 0.54% 48
2018
Q3
$2.37M Buy
34,935
+26,770
+328% +$1.71M 0.53% 49
2018
Q2
$473K Buy
+8,165
New +$461K 0.13% 130

Other funds holding MRK

Dakota Wealth Management's MRK Position: Q1 2026 in Review

Dakota Wealth Management increased its Merck (MRK) stake by 29% in Q1 2026, buying an estimated $6.07M and bringing the position to 233,345 shares worth $28.1M. The position accounts for 0.61% of the portfolio, ranked #42.

Dakota Wealth Management first reported a position in MRK in Q2 2018 and has held it in 32 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Dakota Wealth Management held 233,345 shares of Merck worth $28.1M as of Q1 2026.
  • Dakota Wealth Management bought 52,548 Merck shares in Q1 2026, an estimated $6.07M.
  • Merck made up 0.61% of Dakota Wealth Management's portfolio in Q1 2026, its #42 holding.
  • Dakota Wealth Management first reported a position in Merck in Q2 2018 and has held it in 32 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Dakota Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.